[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367671-105":59,"doc-detail-367671-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-evolving-role-of-positron-emission-tomography-in-precision-prostate-cancer-biopsy","The evolving role of positron emission tomography in precision prostate cancer biopsy","","Prostate cancer is among the most common cancers in men, making accurate detection and diagnosis essential for effective treatment planning. Diagnostic prostate biopsy underpins detection and characterization, including Gleason scoring and risk assessment. This narrative review explains how positron emission tomography (PET), especially PSMA radiotracer imaging, improves prostate cancer detection and how hybrid PET/MRI can better localize clinically significant lesions. It also summarizes major evidence, current limitations such as cost and scan time, and emerging molecular probes including GRPR and FAPI to support personalized image-guided biopsy decisions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-evolving-role-of-positron-emission-tomography-in-precision-prostate-cancer-biopsy/367671/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-evolving-role-of-positron-emission-tomography-in-precision-prostate-cancer-biopsy/367671.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is diagnostic prostate biopsy crucial in prostate cancer care?","Question",{"text":113,"@type":114},"Prostate biopsy confirms diagnosis and supports Gleason score determination, which guides treatment decisions and provides prognostic information.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What are the main limitations of TRUS-guided prostate biopsy?",{"text":118,"@type":114},"TRUS cannot accurately visualize tumors in certain prostate regions, which can lead to missed clinically significant cancer, and it carries risks such as infection, bleeding, discomfort, and other procedure-related complications.",{"name":120,"@type":111,"acceptedAnswer":121},"How does PSMA PET and hybrid PET/MRI improve precision in biopsy planning?",{"text":122,"@type":114},"PSMA PET improves detection, and when combined with MRI in PET/MRI systems, it increases sensitivity and specificity to more precisely localize clinically significant lesions for targeted biopsy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},367671,1790196502,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","DOI: 10. 1111/eci.70062  \nNARRATIVE REVIEW  \nThe evolving role of positron emission tomography in precision prostate cancer biopsy  \nAlessio Imperiale1,2,3  | Valentina Berti4,5 | Roberto Luigi Cazzato6 |  \nDarejan Mamulashvili Bessac1,2 | Alice Ressault7 | Luca Vaggelli4 | Mehdi Helali1 | Camilo Garcia8  | Hervé Lang9 | Desirée Deandreis8 | Luc Mertz10 | Afshin Gangi6  \n1Nuclear Medicine, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France  \n2Nuclear Medicine and Molecular Imaging, ICANS, Strasbourg, France 3IPHC, UMR 7178, CNRS/Unistra, Strasbourg, France  \n4Nuclear Medicine, Careggi University Hospital, Florence, Italy 5Experimental and Clinical Biomedical Sciences ‘Mario Serio’, Florence University, Florence, Italy 6Interventional Radiology, Strasbourg University Hospitals, Strasbourg University, Strasbourg, France 7Radiopharmacy, Strasbourg University Hospitals, Strasbourg University, Strasbourg, France  \n8Nuclear Medicine, Institut GustaveRoussy, Université Paris-Saclay, Villejuif, France  \n9Urology, Strasbourg University Hospitals, Strasbourg University, Strasbourg, France  \n10Radiophysics, University Hospitals of Strasbourg, Strasbourg, France  \nCorrespondence  \nAlessio Imperiale, Nuclear Medicine Physician, Médecine Nucléaire et Imagerie Moléculaire, ICANSHôpitaux Universitaires de Strasbourg, 17, rue Albert Calmette, 67093 Strasbourg, France. [Email:](Email: a.imperiale@icans.eu)[ a.imperiale@icans.eu](Email: a.imperiale@icans.eu)  \nAbstract  \nProstate cancer is one of the most common cancers among men, and accurate detection and diagnosis are crucial for effective treatment planning. Diagnostic prostate biopsy plays a pivotal role in the detection and characterization of prostate cancer. Recent advancements in molecular imaging, particularly with Positron Emission Tomography (PET) using radiolabelled Prostate-Specific Membrane Antigen (PSMA) tracers, have shown significant improvements in enhancing prostate cancer detection. PSMA PET, when combined with magnetic resonance imaging (MRI) in hybrid PET/MRI systems, provides improved sensitivity and specificity, enabling more precise localization of clinically significant prostate cancer (csPCa) lesions. This narrative review explores the evolving role of PET/ CT and PET/MRI-guided prostate biopsy. We examine the integration of PET with MRI for the detection of prostate cancer, highlighting key studies that have demonstrated improved diagnostic outcomes. Additionally, we discuss the current limitations, including the high costs and longer scan times associated with PET/MRI, as well as the challenges in data interpretation. The review also considers emerging technologies, such as promising molecular probes for prostate PET imaging, such as gastrin-releasing peptide receptor (GRPR) and fibroblast activation protein inhibitor (FAPI). Finally, the present work provides the clinician with a comprehensive yet concise up-to-date review of the literature to easily evaluate the possibilities currently offered by hybrid imaging technologies of personalized imaging-guided biopsy for prostate cancer patients.  \nKEYWORDS  \nbiopsy, image-guided, MRI, PET, prostate cancer, PSMA  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s). European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.  \nEur J Clin Invest. 2025;55:e70062 .  \n[https://doi.org/10.1111/eci.70062](https://doi.org/10.1111/eci.70062)  \n[wileyonlinelibrary.com/journal/eci](wileyonlinelibrary.com/journal/eci)  \n1 of 13  \n1 | PROSTATE CANCER BIOPSY: AN OVERVIEW  \nProstate carcinoma is one of the most common cancersin men worldwide, typically affecting older individuals. Clinically, prostate cancer often remains asymptoma","cbCairEZl6uC8jkM","https://ap.wps.com/l/cbCairEZl6uC8jkM","pdf",1102387,13,"English","# Prostate cancer biopsy: an overview\n## Role of diagnostic biopsy and Gleason score\n## Limitations of TRUS-guided systematic biopsy\n# PET for precision prostate cancer diagnosis\n## PSMA PET advances in detection and localization\n## Hybrid PET/MRI for improved specificity and sensitivity\n# PET/CT and PET/MRI-guided biopsy workflow\n## Integration of PET with MRI for targeted sampling\n# Current limitations and emerging technologies\n## Costs, scan time, and data interpretation challenges\n## Emerging molecular probes (GRPR, FAPI)","[{\"question\":\"Why is diagnostic prostate biopsy crucial in prostate cancer care?\",\"answer\":\"Prostate biopsy confirms diagnosis and supports Gleason score determination, which guides treatment decisions and provides prognostic information.\"},{\"question\":\"What are the main limitations of TRUS-guided prostate biopsy?\",\"answer\":\"TRUS cannot accurately visualize tumors in certain prostate regions, which can lead to missed clinically significant cancer, and it carries risks such as infection, bleeding, discomfort, and other procedure-related complications.\"},{\"question\":\"How does PSMA PET and hybrid PET/MRI improve precision in biopsy planning?\",\"answer\":\"PSMA PET improves detection, and when combined with MRI in PET/MRI systems, it increases sensitivity and specificity to more precisely localize clinically significant lesions for targeted biopsy.\"}]","The evolving role of positron emission tomography in precision prostate cancer biopsy | PDF",1790171905,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9918ffa767a4f7de4ab8bf3d38179e7.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d9ad51ab2f9d398e7c950f650dd5dca.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/291782c48854f2c5212f9a9bc8de2ddc.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/100049378686013ec416931ae2e2e1c6.webp",980,1287]